AMPK and PPARdelta agonists are exercise mimetics - Test2 - elhamkhani - TriplyDB

AMPK and PPARdelta agonists are exercise mimetics

AMPK and PPARdelta agonists are exercise mimetics

http://www.wikidata.org/entity/Q24652674

about

AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder The effects of testosterone deprivation and supplementation on proteasomal and autophagy activity in the skeletal muscle of the male mouse: differential effects on high-androgen responder and low-androgen responder muscle groups The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway AMP-activated protein kinase, stress responses and cardiovascular diseases The AMPK signalling pathway coordinates cell growth, autophagy and metabolism Genetic determinants of voluntary exercise Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy PPARs and the cardiovascular system Integration of microRNA miR-122 in hepatic circadian gene expression Adenosine monophosphate-activated protein kinase in diabetic nephropathy Nuclear receptors and AMPK: can exercise mimetics cure diabetes?Can physical exercise in old age improve memory and hippocampal function?Energy disruptors: rising stars in anticancer therapy?PPARs: Protectors or Opponents of Myocardial Function?Caloric restriction and exercise "mimetics'': Ready for prime time?Mechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral Sclerosis Nutrition and the adaptation to endurance training Running forward: new frontiers in endurance exercise biology Road to exercise mimetics: targeting nuclear receptors in skeletal muscle Nutrition facts in multiple sclerosis Nuclear receptors and AMPK: resetting metabolism Past strategies and future directions for identifying AMP-activated protein kinase (AMPK) modulators AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function Muscle function in COPD: a complex interplay Mitochondrial biogenesis through activation of nuclear signaling proteins General aspects of muscle glucose uptake Transcriptional repression of mitochondrial function in aging: a novel role for the silencing mediator of retinoid and thyroid hormone receptors co-repressor All about running: synaptic plasticity, growth factors and adult hippocampal neurogenesis GSK-3 as potential target for therapeutic intervention in cancer Age effect on myocellular remodeling: response to exercise and nutrition in humans Nutrient sensing, metabolism, and cell growth control AMPK activation through mitochondrial regulation results in increased substrate oxidation and improved metabolic parameters in models of diabetes Altered metabolism and persistent starvation behaviors caused by reduced AMPK function in Drosophila Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy Identification of yeast and human 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAr) transporters MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response Chaperoning to the metabolic party: The emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice

P2860

Q24314272-A3315427-D9F3-4076-ACAE-480EE9F34946 Q24596896-B9ED06BF-FD31-421F-BDFD-BB35A8813B02 Q24601222-9F2B2329-A20F-4752-9CBA-E5F82B2C0AF0 Q24607012-7E47D8B2-3A88-4832-B581-F51B69E95632 Q24610297-0BC628A3-D6CA-49B9-A5C1-E78D1F9FF539 Q24616273-8FE62D79-C7A3-462D-8662-E23DA0E392D2 Q24618946-D1A58D46-A081-4F1B-988C-A4149643E5EE Q24634396-0156DB08-BD6C-4A41-919E-357DCF77DC59 Q24642728-13F7B410-968F-4BE8-A1D5-AD82142BBE2F Q24657953-16006074-9C63-46D6-ABB5-65619B25F330 Q26745623-5CADB641-5F2B-4D51-A9BD-03617287A631 Q26750875-1B617D4D-36C0-4360-9395-13F212E1725B Q26766517-58076ADC-B9F0-4FCC-A3C0-13D4EFD2E3D7 Q26771300-1FE1136E-D5BA-46BF-9F90-3FFF6C1E7B18 Q26771753-4C27A5A2-0EC2-45D4-8947-32ADE41612FD Q26776446-0F1D6A16-12FC-4B3A-9D87-C9C829D0158C Q26783337-D2A7AFA2-821C-45A6-94D1-9BDDEC717932 Q26823566-D0A87E0E-E162-44B1-AC53-A7A918FDC8BE Q26824141-05CE7C47-360A-4D78-B271-856CB2D00688 Q26825855-320F17BB-0623-49F7-A711-6859A5BFEFE1 Q26851247-A5D46A06-349E-47EA-8C9F-A1F3A849A969 Q26852804-6840A027-CB5A-4AA9-A620-EFE93EF63FB9 Q26864679-74AB87DF-5CB2-4D6F-AEDC-AA42348A48B0 Q26865723-85E90470-3600-4971-BB98-1EF9E92E2352 Q26865732-8EAD1737-A29C-431B-AB4C-E517E1B59E45 Q26991546-7C8E050E-8EB7-43A7-BB98-566F08DC480C Q26991925-E7F71115-6F30-41A0-A96B-1865FD065228 Q26992046-C8F6D56A-B48F-4E29-A481-E58F53819B61 Q27011760-924AE617-422D-4F2F-BF7F-012365BEDA59 Q27013811-9FA3F7B6-4EF9-4B6E-BE76-FD6DF3C08F65 Q27024546-4BA1F5BB-E427-410D-9A6E-0531B716214E Q27024772-ACBCF5A2-DB14-4ABB-B0DC-C356BE7786C6 Q27300811-CE22F1F0-138C-4521-9076-1D7EAD86208A Q27320050-4F7BCF02-6375-44DA-9DE0-4C764B68EA53 Q27666968-CD45D4E4-AEEE-47E2-989E-D97892770680 Q27938996-8DB29685-E074-471B-8A4C-FCFCB5A30975 Q28067635-18358AA4-2303-4885-90E1-FBA591FC14A3 Q28114977-7C4BDE16-696C-4783-85BD-7ADA6D73DEA7 Q28251174-E2B14BB7-BA66-4DFB-AFFE-7B0685FD9FC7 Q28302954-86555FBB-76A1-4A62-81FC-6AFB0385FFA7

P2860

AMPK and PPARdelta agonists are exercise mimetics

http://www.wikidata.org/entity/Q24652674

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

AMPK and PPARdelta agonists are exercise mimetics

@ast

AMPK and PPARdelta agonists are exercise mimetics

@en

AMPK and PPARdelta agonists are exercise mimetics

@nl

type

label

AMPK and PPARdelta agonists are exercise mimetics

@ast

AMPK and PPARdelta agonists are exercise mimetics

@en

AMPK and PPARdelta agonists are exercise mimetics

@nl

prefLabel

AMPK and PPARdelta agonists are exercise mimetics

@ast

AMPK and PPARdelta agonists are exercise mimetics

@en

AMPK and PPARdelta agonists are exercise mimetics

@nl

P1433

Q24652674-85163E7F-8C1E-4D6E-864F-6B5F82538034

P1476

Q24652674-B00479CB-4B53-4620-A2DB-A5EEFF821831

P2093

Q24652674-1426FB04-B3CC-4CB4-8519-271F62DA9936

Q24652674-1539EAEE-67EF-417E-95F3-65F3DE47D02A

Q24652674-218F40A3-5306-43B7-BDE5-8F52255085E0

Q24652674-2CACCE4C-4CDF-4F26-A44B-DF0169E2495B

Q24652674-312466A9-B794-4ECE-9FEE-96A392BD5DD3

Q24652674-666552E4-AC9C-4A7C-B308-9D1DC6C73C1F

Q24652674-8DAC8A3B-B907-4104-8814-90294ADC40E7

Q24652674-A40AAC39-13E8-4C5A-9BBC-B6E91623D240

Q24652674-AE3B4650-3541-4C11-B989-96858380BF24

Q24652674-E2BBB73C-CEE6-482D-A849-ED19F9D59FF4

P2860

Q24652674-00E0F2A9-49A7-43E2-9BF3-2F0E5C7FCA5F

Q24652674-054B7973-3144-441F-849E-21A4D486C868

Q24652674-06B8644E-0C25-4C58-A87E-D6C11DB5AB6D

Q24652674-0894ED95-38D0-499E-897F-BF94DFFDB56D

Q24652674-0A4ACA74-63B1-4367-80F0-0B10A7DF29F0

Q24652674-0B8A95ED-1A37-48BA-B05C-F06467CAB873

Q24652674-0BB9AAAF-5158-4CC3-86EA-BBC40C280135

Q24652674-1277B91C-5C99-4CBD-9A5B-F5C074612588

Q24652674-142CAC39-A444-4E13-880E-F6578CC4193D

Q24652674-1444DE23-34FC-47BF-BCFE-9AAA1A8A056A

P304

Q24652674-34FAC64F-C3C3-48B4-8129-DC7C9B0A29AC

P31

Q24652674-E0130021-462C-4009-AA73-F3D0BDB05BFF

P3181

Q24652674-CBCA934E-6762-41CC-B6ED-333BE3D79577

P356

Q24652674-221CAD27-CC9A-4809-AF50-9F2935450BC2

P407

Q24652674-BA3D4693-9873-4BF3-AAE8-C9B7ECF872D2

P433

Q24652674-5D3F26A4-96DE-4AB7-A3DE-F010337DC861

P478

Q24652674-EF6A7C6F-A0EB-4230-AC74-7A74775D1BDC

P50

Q24652674-1272A0F0-4337-4D93-8990-A8D3DD7B5639

P577

Q24652674-5D762A37-B578-4691-A8B4-23C30B8121E8

P5875

Q24652674-0DD82C8E-A467-4817-BD40-D72B3BF7E751

P698

Q24652674-D60B4095-F59D-4679-B3E2-E60C67F0A339

P932

Q24652674-59F863D7-8DC2-44A8-885B-0A63FD8F0410

P3181

P356

J.CELL.2008.06.051

P1433

P1476

AMPK and PPARdelta agonists are exercise mimetics

@en

P2093

Emi Embler

http://www.w3.org/2001/XMLSchema#string

Ester Banayo

http://www.w3.org/2001/XMLSchema#string

Henry Juguilon

http://www.w3.org/2001/XMLSchema#string

Heonjoong Kang

http://www.w3.org/2001/XMLSchema#string

Maria M Mihaylova

http://www.w3.org/2001/XMLSchema#string

Michael C Nelson

http://www.w3.org/2001/XMLSchema#string

Michael Downes

http://www.w3.org/2001/XMLSchema#string

Reuben J Shaw

http://www.w3.org/2001/XMLSchema#string

Ruth T Yu

http://www.w3.org/2001/XMLSchema#string

Vihang A Narkar

http://www.w3.org/2001/XMLSchema#string

P2860

Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta

Software and methods for oligonucleotide and cDNA array data analysis.

Regulation of muscle fiber type and running endurance by PPARdelta

A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle

AMP-activated protein kinase plays a role in the control of food intake

AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

Myogenin and oxidative enzyme gene expression levels are elevated in rat soleus muscles after endurance training

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

P304

405-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1164119

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CELL.2008.06.051

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Ronald M. Evans

P577

2008-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23144151

http://www.w3.org/2001/XMLSchema#string

P698

18674809

http://www.w3.org/2001/XMLSchema#string

P932

2706130

http://www.w3.org/2001/XMLSchema#string